Evidence map›Paper›PMID 35161103›Full record

ArticleMaterials (Basel, Switzerland)2022

Maleic Anhydride Polylactic Acid Coupling Agent Prepared from Solvent Reaction: Synthesis, Characterization and Composite Performance.

Helena Oliver-Ortega, Rafel Reixach, Francesc Xavier Espinach, José Alberto Méndez

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Helena Oliver-OrtegaGroup LEPAMAP-PRODIS, Department of Chemical Engineering, University of Girona, 17003 Girona, Spain.ORCID 0000-0002-9398-8112
Rafel ReixachGroup LEPAMAP-PRODIS, Department of Chemical Engineering, University of Girona, 17003 Girona, Spain.
Francesc Xavier EspinachGroup LEPAMAP-PRODIS, Department of Chemical Engineering, University of Girona, 17003 Girona, Spain.ORCID 0000-0002-6635-0260
José Alberto MéndezGroup LEPAMAP-PRODIS, Department of Chemical Engineering, University of Girona, 17003 Girona, Spain.ORCID 0000-0003-0417-8431
Universitat de Girona · ES

Funding

Ministry of Economy, Industry and Competitiveness MAT2017-83347-R
6 · The paper itself

Abstract

In the present work, a functionalization of polylactic acid (PLA) has been carried out to anchor maleic anhydride onto the main polymer chain to promote improvement in the compatibility of this polymer matrix with cellulose fibres. Low-molecular-weight PLA has been reacted with maleic anhydride following different procedures: a bulk reaction in an internal mixer and a solution reaction. The presence of oxygen during bulk processing did not allow for functionalization, guiding the reaction towards a decrease in the molecular weight of the material. On the contrary, a controlled reaction under an inert atmosphere in the presence of dioxane as the solvent, at reflux temperature, led to the functionalization of the polymer reaching different yields depending on the percentage of radical initiator and maleic anhydride added and reaction time. The yield of functionalization has been monitored by acid number titration as well as 1H NMR, with optimal yield values of functionalization being up to 3.5%. The PLA-functionalized formula has been used to make commercial PLA compatible with cellulose fibres derived from a thermomechanical treatment. The addition of 10%

Indexed as

biocompositescoupling agentpolylactic acid (PLA)

Identifiers

PMID35161103
PMCPMC8838346
OpenAlexW4210634005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.